The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study
Open accessAbstract
BACKGROUND: Plasmodium vivax exacts a significant toll on health worldwide, yet few efforts to date have quantified the extent and temporal trends of its global distribution. Given the challenges associated with the proper diagnosis and treatment of P vivax, national malaria programmes-particularly those pursuing malaria elimination strategies-require up to date assessments of P vivax endemicity and disease impact. This study presents the first global maps of P vivax clinical burden from 2000 to 2017. METHODS: In this spatial and temporal modelling study, we adjusted routine malariometric surveillance data for known biases and used socioeconomic indicators to generate time series of the clinical burden of P vivax. These data informed Bayesian geospatial models, which produced fine-scale predictions of P vivax clinical incidence and infection prevalence over time. Within sub-Saharan Africa, where routine surveillance for P vivax is not standard practice, we combined predicted surfaces of Plasmodium falciparum with country-specific ratios of P vivax to P falciparum. These results were combined with surveillance-based outputs outside of Africa to generate global maps. FINDINGS: We present the first high-resolution maps of P vivax burden. These results are combined with those for P falciparum (published separately) to form the malaria estimates for the Global Burden of Disease 2017 study. The burden of P vivax malaria decreased by 41·6%, from 24·5 million cases (95% uncertainty interval 22·5-27·0) in 2000 to 14·3 million cases (13·7-15·0) in 2017. The Americas had a reduction of 56·8% (47·6-67·0) in total cases since 2000, while South-East Asia recorded declines of 50·5% (50·3-50·6) and the Western Pacific regions recorded declines of 51·3% (48·0-55·4). Europe achieved zero P vivax cases during the study period. Nonetheless, rates of decline have stalled in the past five years for many countries, with particular increases noted in regions affected by political and economic instability. INTERPRETATION: Our study highlights important spatial and temporal patterns in the clinical burden and prevalence of P vivax. Amid substantial progress worldwide, plateauing gains and areas of increased burden signal the potential for challenges that are greater than expected on the road to malaria elimination. These results support global monitoring systems and can inform the optimisation of diagnosis and treatment where P vivax has most impact. FUNDING: Bill & Melinda Gates Foundation and the Wellcome Trust.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most P. vivax cases are in geographic areas of the WHO Regional Offices for South-East Asia and Eastern Mediterranean [19]”
From Global estimates of pregnancies at risk of Plasmodium falciparum and Plasmodium vivax infection in 2020 and changes in risk patterns since 2000 (2022) · cites this paper as [19]
In the citing paper
“Since 2007 there have been decreases in the prevalence of P. falciparum [12] and P. vivax [19], as well as global fertility rates [21, 22], although absolute populations have grown at regional and global levels.”
From Global estimates of pregnancies at risk of Plasmodium falciparum and Plasmodium vivax infection in 2020 and changes in risk patterns since 2000 (2022) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationThe effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
Bhatt, S., Weiss, D. J., Cameron, E., Bisanzio, D., Mappin, B., Dalrymple, U., Battle, K. E., Moyes, C. L., Henry, A., Eckhoff, P. A., et al. (2015) · Nature · doi:10.1038/nature15535 · Cited by 3,225
Self-citationThe Resistance Factor toPlasmodium vivaxin Blacks
Miller, L. H., Mason, S. J., CLYDE, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,259
The global distribution and population at risk of malaria: past, present, and future
Hay, S. I., Guerra, C. A., Tatem, A. J., Noor, A. M., & Snow, R. W. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01043-6 · Cited by 1,002
The neglected burden of Plasmodium vivax malaria
Mendis, K., Sina, B. J., Marchesini, P. B., & Carter, R. (2001) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.97 · Cited by 976
Vivax Malaria: Neglected and Not Benign
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M. (2007) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.79 · Cited by 840
Asymptomatic malaria infections: detectability, transmissibility and public health relevance
Bousema, T., Okell, L., Felger, I., & DRAKELEY, C. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3364 · Cited by 685
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Müeller, I., Galinski, M. R., Baird, J. K., Carlton, J. M., Kochar, D. K., Alonso, P. L., & Portillo, H. A. D. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70177-x · Cited by 661
A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010
Gething, P. W., Elyazar, I., Moyes, C. L., Smith, D. L., Battle, K. E., Guerra, C. A., Patil, A. P., Tatem, A. J., Howes, R. E., Myers, M. F., et al. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001814 · Cited by 560
Self-citationWeiss, D. J., Lucas, T. C. D., Nguyen, M., Nandi, A. K., Bisanzio, D., Battle, K. E., Cameron, E., Twohig, K. A., Pfeffer, D. A., Rozier, J. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31097-9 · Cited by 469
Self-citationThe International Limits and Population at Risk of Plasmodium vivax Transmission in 2009
Guerra, C. A., Howes, R. E., Patil, A. P., Gething, P. W., Boeckel, T. P. V., Temperley, W. H., Kabaria, C. W., Tatem, A. J., Manh, B. H., Elyazar, I., et al. (2010) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000774 · Cited by 468
The global distribution of the Duffy blood group
Howes, R. E., Patil, A. P., Piel, F. B., Nyangiri, O. A., Kabaria, C. W., Gething, P. W., Zimmerman, P. A., Barnadas, C., Beall, C. M., Gebremedhin, A., et al. (2011) · Nature Communications · doi:10.1038/ncomms1265 · Cited by 403
Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria
Baird, J. K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-12 · Cited by 398
Nabarro, D. N. (1999) · PubMed · Cited by 289
Geographical variation in Plasmodium vivax relapse
Battle, K. E., Karhunen, M., Bhatt, S., Gething, P. W., Howes, R. E., Golding, N., Boeckel, T. P. V., Messina, J. P., Shanks, G. D., Smith, D. L., et al. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-144 · Cited by 278
Self-citationMalaria: Global progress 2000 – 2015 and future challenges
Cibulskis, R. E., Alonso, P., Aponte, J., Aregawi, M., Barrette, A., Bergeron, L., Fergus, C. A., Knox, T., Lynch, M., Patouillard, E., et al. (2016) · Infectious Diseases of Poverty · doi:10.1186/s40249-016-0151-8 · Cited by 266
Growing evidence of Plasmodium vivax across malaria-endemic Africa
Twohig, K. A., Pfeffer, D. A., Baird, J. K., Price, R. N., Zimmerman, P. A., Hay, S. I., Gething, P. W., Battle, K. E., & Howes, R. E. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007140 · Cited by 192
Self-citationBone Marrow Is a Major Parasite Reservoir in Plasmodium vivax Infection
Obaldía, N., Meibalan, E., Sá, J. M., Ma, S., Clark, M. A., Mejia, P., Barros, R. R. M., Otero, W., Ferreira, M. U., Mitchell, J. R., et al. (2018) · mBio · doi:10.1128/mbio.00625-18 · Cited by 191
Galactionova, K., Tediosi, F., de Savigny, D., Smith, T. A., & Tanner, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127818 · Cited by 171
Vivax Malaria: A Major Cause of Morbidity in Early Infancy
Poespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Hasanuddin, A., Warikar, N., Sugiarto, P., Tjitra, E., Anstey, N., & Price, R. N. (2009) · Clinical Infectious Diseases · doi:10.1086/599041 · Cited by 164
Management of relapsingPlasmodium vivaxmalaria
Chu, C. S., & White, N. J. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1220304 · Cited by 139
Worldwide Incidence of Malaria in 2009: Estimates, Time Trends, and a Critique of Methods
Cibulskis, R. E., Aregawi, M. W., Williams, R. O., Otten, M. W., & Dye, C. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001142 · Cited by 138
Plasmodium vivax Transmission in Africa
Howes, R. E., Reiner, R. C., Battle, K. E., Longbottom, J., Mappin, B., Ordanovich, D., Tatem, A. J., DRAKELEY, C. J., Gething, P. W., Zimmerman, P. A., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004222 · Cited by 134
Self-citationmalariaAtlas: an R interface to global malariometric data hosted by the Malaria Atlas Project
Pfeffer, D. A., Lucas, T. C. D., May, D. S., Harris, J., Rozier, J. A., Twohig, K. A., Dalrymple, U., Guerra, C. A., Moyes, C. L., Thorn, M., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2500-5 · Cited by 122
Self-citationMalaria Elimination: Time to Target All Species
Lover, A. A., Baird, J. K., Gosling, R. D., & Price, R. N. (2018) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.17-0869 · Cited by 99
Baird, J. K., Louisa, M., Noviyanti, R., Ekawati, L. L., Elyazar, I., Subekti, D., Chand, K., Gayatri, A., Instiaty, Soebianto, S., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1449 · Cited by 99
Cameron, E., Battle, K. E., Bhatt, S., Weiss, D. J., Bisanzio, D., Mappin, B., Dalrymple, U., Hay, S. I., Smith, D. L., Griffin, J. T., et al. (2015) · Nature Communications · doi:10.1038/ncomms9170 · Cited by 95
Self-citationThriemer, K., Bobogare, A., Ley, B., Gudo, C. S., Alam, M. S., Anstey, N., Ashley, E. A., Baird, J. K., Gryseels, C., Jambert, E., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2380-8 · Cited by 90
Self-citationFine-scale malaria risk mapping from routine aggregated case data
Sturrock, H. J. W., Cohen, J. M., Keil, P., Tatem, A. J., Menach, A. L., Ntshalintshali, N., Hsiang, M. S., & Gosling, R. D. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-421 · Cited by 78
Baird, J. K., Battle, K. E., & Howes, R. E. (2018) · Malaria Journal · doi:10.1186/s12936-018-2190-z · Cited by 78
Self-citationLog Gaussian Cox processes and spatially aggregated disease incidence data
Li, Y., Brown, P., Gesink, D., & Rue, H. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280212446326 · Cited by 46
Deressa, W. A. (2007) · Malaria Journal · doi:10.1186/1475-2875-6-49 · Cited by 43
Battle, K. E., Guerra, C. A., Golding, N., Duda, K. A., Cameron, E., Howes, R. E., Elyazar, I., Baird, J. K., Reiner, R. C., Gething, P. W., et al. (2015) · Scientific Data · doi:10.1038/sdata.2015.12 · Cited by 30
Self-citationDefining the relationship between Plasmodium vivax parasite rate and clinical disease
Battle, K. E., Cameron, E., Guerra, C. A., Golding, N., Duda, K. A., Howes, R. E., Elyazar, I., Price, R. N., Baird, J. K., Reiner, R. C., et al. (2015) · Malaria Journal · doi:10.1186/s12936-015-0706-3 · Cited by 15
Self-citationNelson, K. J., Clarke, J. H., & Kift, S. (2011) · Student Success · doi:10.5204/intjfyhe.v2i1.69 · Cited by 2
Cited by
Sorted by citations
Weiss, D. J., Lucas, T. C. D., Nguyen, M., Nandi, A. K., Bisanzio, D., Battle, K. E., Cameron, E., Twohig, K. A., Pfeffer, D. A., Rozier, J. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31097-9 · Cited by 469
Self-citationMalaria eradication within a generation: ambitious, achievable, and necessary
Feachem, R. G., Chen, I., Akbari, O. S., Bertozzi-Villa, A., Bhatt, S., Binka, F. N., Boni, M. F., Buckee, C. O., Dieleman, J. L., Dondorp, A. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31139-0 · Cited by 372
Plasmodium vivax in the Era of the Shrinking P. falciparum Map
Price, R. N., Commons, R. J., Battle, K. E., Thriemer, K., & Mendis, K. (2020) · Trends in Parasitology · doi:10.1016/j.pt.2020.03.009 · Cited by 270
Self-citationMalaria vaccines since 2000: progress, priorities, products
Duffy, P. E., & Gorres, J. P. (2020) · npj Vaccines · doi:10.1038/s41541-020-0196-3 · Cited by 267
Weiss, D. J., Bertozzi-Villa, A., Rumisha, S. F., Amratia, P., Arambepola, R., Battle, K. E., Cameron, E., Chestnutt, E., Gibson, H. S., Harris, J., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30700-3 · Cited by 236
Self-citation
Metadata
- Authors
- Battle, K. E., Lucas, T. C. D., Nguyen, M., Howes, R. E., Nandi, A. K., Twohig, K. A., Pfeffer, D. A., Cameron, E., Rao, P. C., Casey, D., Gibson, H. S., Rozier, J. A., Dalrymple, U., Keddie, S. H., Collins, E. L., Harris, J. R., Guerra, C. A., Thorn, M. P., Bisanzio, D., Fullman, N., Huynh, C. K., Kulikoff, X., Kutz, M. J., Lopez, A. D., Mokdad, A. H., Naghavi, M., Nguyen, G., Shackelford, K. A., Vos, T., Wang, H., Lim, S. S., Murray, C. J. L., Price, R. N., Baird, J. K., Smith, D. L., Bhatt, S., Weiss, D. J., Hay, S. I., & Gething, P. W.
- Affiliations
- University of Oxford (GB)
- Charles Darwin University (AU)
- University of Washington (US)
- Public Health – Seattle & King County (US)
- Public Health England (GB)
- Medical Care Development International (US)
- University of Nottingham (GB)
- Imperial College London (GB)
- Corresponding author
- Gething, Peter W
- ORCID
- Battle, Katherine E
- Lucas, Tim C D
- Howes, Rosalind E
- Nandi, Anita K
- Twohig, Katherine A
- Pfeffer, Daniel A
- Cameron, Ewan
- Gibson, Harry S
- Rozier, Jennifer A
- Dalrymple, Ursula
- Keddie, Suzanne H
- Guerra, Carlos A
- Bisanzio, Donal
- Fullman, Nancy
- Kulikoff, Xie
- Mokdad, Ali H
- Naghavi, Mohsen
- Vos, Theo
- Wang, Haidong
- Lim, Stephen S
- Murray, Christopher J L
- Price, Ric N
- Baird, J Kevin
- Smith, David L
- Bhatt, Samir
- Weiss, Daniel J
- Hay, Simon I
- Gething, Peter W
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 394
- Issue
- 10195
- Pages
- 332-343
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC6675736
- OpenAlex
- W2950607694
- Cited by
- 409
- References
- 36
- Citations by year
- 2026: 31 · 2025: 41 · 2024: 63 · 2023: 69 · 2022: 59 · 2021: 83 · 2020: 49 · 2019: 14
- FWCI
- 47.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Bill and Melinda Gates Foundation
- Wellcome Trust (200909/Z/16/Z, 200909)
- Medical Research Council (MR/R015600/1)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Life Sciences › Immunology and Microbiology › Parasitology › Bird parasitology and diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
- Keywords
- Plasmodium vivax, vivax malaria, malaria endemicity, clinical burden, Plasmodium falciparum, malaria elimination, global burden of disease, sub-Saharan Africa, Americas, Southeast Asia, western Pacific, socio-economic instability
- MeSH terms
- Africa, Americas, Asia, Southeastern, Bayes Theorem, Humans, Population Surveillance, Global Health, Malaria, Vivax, Endemic Diseases, Oceania, Spatio-Temporal Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
